Profile data is unavailable for this security.
About the company
Antengene Corp Ltd is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company's products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The Company mainly conducts its business in Asia-Pacific.
- Revenue in HKD (TTM)95.43m
- Net income in HKD-258.61m
- Incorporated2018
- Employees152.00
- LocationAntengene Corp LtdUgland HousePO Box 309SHANGHAI KY1-1104ChinaCHN
- Websitehttps://www.antengene.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kintor Pharmaceutical Ltd | 12.43m | -189.00m | 1.37bn | 136.00 | -- | 5.04 | -- | 110.36 | -0.437 | -0.437 | 0.0287 | 0.5461 | 0.0194 | 10.66 | 1.06 | 73,966.23 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.04m | -88.28m | 1.40bn | 106.00 | -- | -- | -- | 8.56 | -0.4554 | -0.4554 | 0.8462 | -0.1602 | 0.5805 | 11.54 | 13.96 | 1,451,683.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -329.39m | 1.45bn | 57.00 | -- | 3.65 | -- | -- | -0.7286 | -0.7286 | 0.00 | 0.6934 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -252.85m | 1.57bn | 173.00 | -- | -- | -- | -- | -0.4518 | -0.4518 | 0.00 | -0.2878 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| Cloudbreak Pharma Inc | 78.15m | -326.93m | 1.92bn | 60.00 | -- | -- | -- | 24.58 | -0.3897 | -0.3897 | 0.0932 | -3.08 | -- | -- | -- | 1,532,373.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.82m | -342.43m | 1.96bn | 195.00 | -- | 3.06 | -- | 15.48 | -0.8705 | -0.8705 | 0.3221 | 1.48 | 0.148 | -- | 3,865.48 | 812,941.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 479.59m | -31.09m | 2.10bn | 383.00 | -- | 18.81 | 57.03 | 4.39 | -0.0076 | -0.0076 | 0.1163 | 0.0271 | 0.4209 | 0.4659 | 4.05 | 1,522,523.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.33m | -739.77m | 2.17bn | 507.00 | -- | 10.61 | -- | 176.26 | -1.55 | -1.55 | 0.0258 | 0.4242 | 0.006 | -- | -- | 23,220.65 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.97m | 2.20bn | 1.54k | 73.12 | 0.8238 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9735 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,499.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Antengene Corp Ltd | 95.43m | -258.61m | 2.34bn | 152.00 | -- | 2.70 | -- | 24.56 | -0.4162 | -0.4162 | 0.1536 | 1.28 | 0.0619 | 1.51 | 3.20 | 564,671.80 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.62bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.57m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.76 | -0.8194 | -0.8194 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,238.00 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.21m | 3.25bn | 604.00 | 370.88 | 3.92 | 35.55 | 2.69 | 0.0113 | 0.0113 | 1.66 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,975,381.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Hua Medicine | 419.33m | 1.22bn | 3.30bn | 285.00 | 2.55 | 2.56 | 2.62 | 7.86 | 1.23 | 1.23 | 0.4248 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,496,030.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
Data as of Feb 16 2026. Currency figures normalised to Antengene Corp Ltd's reporting currency: Hong Kong Dollar HKD
1.42%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Templeton Asset Management Ltd. (Hong Kong)as of 31 Dec 2025 | 3.90m | 0.57% |
| Janus Henderson Investors (Singapore) Ltd.as of 31 Dec 2025 | 2.02m | 0.30% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 1.69m | 0.25% |
| Janus Henderson Investors UK Ltd.as of 31 Dec 2025 | 1.13m | 0.17% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 846.00k | 0.13% |
| Templeton Asset Management Ltd.as of 31 Dec 2025 | 62.50k | 0.01% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 0.00 | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
